Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26598747

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2016 Mar 1
First author
Ou SH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2016 Mar 1;34(7):643-5. doi: 10.1200/JCO.2015.65.1406.
    note
    Source null
    related pmid
    26712224
    relationship
    Comment in

Authors and identifiers

  1. name
    Ou SH
    type
    Author
  2. name
    Ahn JS
    type
    Author
  3. name
    De Petris L
    type
    Author
  4. name
    Govindan R
    type
    Author
  5. name
    Yang JC
    type
    Author
  6. name
    Hughes B
    type
    Author
  7. name
    Lena H
    type
    Author
  8. name
    Moro-Sibilot D
    type
    Author
  9. name
    Bearz A
    type
    Author
  10. name
    Ramirez SV
    type
    Author
  11. name
    Mekhail T
    type
    Author
  12. name
    Spira A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Ou SH
    type
    Author
  2. name
    Ahn JS
    type
    Author
  3. name
    De Petris L
    type
    Author
  4. name
    Govindan R
    type
    Author
  5. name
    Yang JC
    type
    Author
  6. name
    Hughes B
    type
    Author
  7. name
    Lena H
    type
    Author
  8. name
    Moro-Sibilot D
    type
    Author
  9. name
    Bearz A
    type
    Author
  10. name
    Ramirez SV
    type
    Author
  11. name
    Mekhail T
    type
    Author
  12. name
    Spira A
    type
    Author
bibliography ids
  1. nci-bib-2b0b7c1862736ed6e012fae9
book metadata
content sha256
70c31ef63443034f4fff726f6ebb6664db57fe3a5d19ba7c73cc9daa77c84fea
document type
citation
dois
  1. 10.1200/jco.2015.63.9443
electronic publication date
display
2015 Nov 23
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26598747
immutable id
pubmed:26598747@70c31ef63443034f4fff726f6ebb6664db57fe3a5d19ba7c73cc9daa77c84fea
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
7
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
661-8
volume
34
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2016 Mar 1;34(7):643-5. doi: 10.1200/JCO.2015.65.1406.
    note
    Source null
    related pmid
    26712224
    relationship
    Comment in
outcomes validated
false
pmid
26598747
provenance
batch id
948d34b0dea86780a31d
provider
NCBI PubMed ESummary
record sha256
eec535003a1423bc458721f19b6b898cc68e2df42df250ff3d64178b577becef
response sha256
11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
retrieved at
2026-09-09T23:47:15.495091+00:00
publication date
display
2016 Mar 1
precision
day
year
2016
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26598747/
title
Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study.

Preserved source evidence · Not medical advice